Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 16/2023

12.08.2023 | Research

Psychiatric disorder and its association with gastrointestinal cancer: a retrospective cohort study with 45,842 patients in Germany

verfasst von: Hannah Moessinger, Louis Jacob, Lee Smith, Ai Koyanagi, Karel Kostev

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 16/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Psychiatric disorders and cancer are both common, and comorbidity has detrimental impacts on cancer outcomes. Previous studies focus on affective disorders which arise after cancer diagnosis, not on the impact of psychiatric disorders on cancer risk. We investigate the association between psychiatric disorders and subsequent gastrointestinal cancer in a large cohort in Germany.

Methods

This case–control study used secondary data (electronic medical records) from the national IQVIA Disease Analyzer database. We evaluated the association between previous psychiatric diagnosis in 44,582 matched patients with and without gastrointestinal (GI) cancer. Regression analyses were stratified by psychiatric diagnosis and adjusted by chronic comorbidities and previous psychiatric treatments.

Results

No association between any previous psychiatric disease and GI cancers was found (OR = 0.98 (0.95–1.02 95%CL, p = 0.39). Previous psychosomatic disorder and GI cancer showed a significant negative association (OR: 0.86, 0.81–0.90 95%CL, p < 0.0001). No association was found between previous diagnosis with depression or PTSD and GI cancer. These results remained consistent when including previous psychiatric treatments in the regression analyses.

Conclusion

Psychiatric disease was not associated with GI cancer risk. Further investigation into the pathways linking psychiatric disease and cancer needs to be conducted, taking into consideration psychiatric treatments administered, to enhance our understanding of the relationship between these two common and devastating diseases.
Literatur
Zurück zum Zitat Amerio A, Gálvez JF, Odone A, Dalley SA, Ghaemi SN (2015) Carcinogenicity of psychotropic drugs: a systematic review of US food and drug administration–required preclinical in vivo studies. Aust N Z J Psychiatry 49:686–696PubMedCrossRef Amerio A, Gálvez JF, Odone A, Dalley SA, Ghaemi SN (2015) Carcinogenicity of psychotropic drugs: a systematic review of US food and drug administration–required preclinical in vivo studies. Aust N Z J Psychiatry 49:686–696PubMedCrossRef
Zurück zum Zitat Avila C et al (2015) An overview of links between obesity and mental health. Curr. Obes. Rep. 43(4):303–310CrossRef Avila C et al (2015) An overview of links between obesity and mental health. Curr. Obes. Rep. 43(4):303–310CrossRef
Zurück zum Zitat Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M (2016) Declining bowel cancer incidence and mortality in Germany. Dtsch Ärztebl Int 113:101–106PubMedPubMedCentral Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M (2016) Declining bowel cancer incidence and mortality in Germany. Dtsch Ärztebl Int 113:101–106PubMedPubMedCentral
Zurück zum Zitat Brown S, Kim M, Mitchell C, Inskip H (2010) Twenty–five year mortality of a community cohort with schizophrenia. Br J Psychiatry J Ment Sci 196:116–121CrossRef Brown S, Kim M, Mitchell C, Inskip H (2010) Twenty–five year mortality of a community cohort with schizophrenia. Br J Psychiatry J Ment Sci 196:116–121CrossRef
Zurück zum Zitat Caliri AW, Tommasi S, Besaratinia A (2021) Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer. Mutat Res Rev Mutat Res 787:108365PubMedCrossRef Caliri AW, Tommasi S, Besaratinia A (2021) Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer. Mutat Res Rev Mutat Res 787:108365PubMedCrossRef
Zurück zum Zitat Cardoso R, Guo F, Heisser T, Hoffmeister M, Brenner H (2021) Incidence and mortality of proximal and distal colorectal cancer in Germany. Dtsch Ärztebl 118:281–287 Cardoso R, Guo F, Heisser T, Hoffmeister M, Brenner H (2021) Incidence and mortality of proximal and distal colorectal cancer in Germany. Dtsch Ärztebl 118:281–287
Zurück zum Zitat Charlson ME et al (2008) The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 61:1234–1240PubMedCrossRef Charlson ME et al (2008) The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 61:1234–1240PubMedCrossRef
Zurück zum Zitat Currier MB, Nemeroff CB (2014) Depression as a risk factor for cancer: from pathophysiological advances to treatment implications. Annu Rev Med 65:203–221PubMedCrossRef Currier MB, Nemeroff CB (2014) Depression as a risk factor for cancer: from pathophysiological advances to treatment implications. Annu Rev Med 65:203–221PubMedCrossRef
Zurück zum Zitat DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta–analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107PubMedCrossRef DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta–analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107PubMedCrossRef
Zurück zum Zitat Dinesh AA, Helena Pagani Soares Pinto S, Brunckhorst O, Dasgupta P, Ahmed K (2021) Anxiety, depression and urological cancer outcomes: A systematic review. Urol. Oncol. Semin. Orig. Investig. 39:816–828 Dinesh AA, Helena Pagani Soares Pinto S, Brunckhorst O, Dasgupta P, Ahmed K (2021) Anxiety, depression and urological cancer outcomes: A systematic review. Urol. Oncol. Semin. Orig. Investig. 39:816–828
Zurück zum Zitat Dragioti E et al (2023) Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction. World Psychiatry. 22:86–104PubMedPubMedCentralCrossRef Dragioti E et al (2023) Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction. World Psychiatry. 22:86–104PubMedPubMedCentralCrossRef
Zurück zum Zitat Fang H-F et al (2019) Association between sedative–hypnotics and subsequent cancer in patients with and without insomnia: a 14–year follow–up study in Taiwan. J Cancer 10:2288–2298PubMedPubMedCentralCrossRef Fang H-F et al (2019) Association between sedative–hypnotics and subsequent cancer in patients with and without insomnia: a 14–year follow–up study in Taiwan. J Cancer 10:2288–2298PubMedPubMedCentralCrossRef
Zurück zum Zitat Feng L, Li Z, Gu X, Jiang J, Liu X (2021) Psychosomatic disorders in patients with gastrointestinal diseases: single-center cross–sectional study of 1186 inpatients. Gastroenterol Res Pract 2021:e6637084CrossRef Feng L, Li Z, Gu X, Jiang J, Liu X (2021) Psychosomatic disorders in patients with gastrointestinal diseases: single-center cross–sectional study of 1186 inpatients. Gastroenterol Res Pract 2021:e6637084CrossRef
Zurück zum Zitat Gao Z et al (2022) Antipsychotic exposure is an independent risk factor for breast cancer: a systematic review of epidemiological evidence. Front Oncol 12:993367PubMedPubMedCentralCrossRef Gao Z et al (2022) Antipsychotic exposure is an independent risk factor for breast cancer: a systematic review of epidemiological evidence. Front Oncol 12:993367PubMedPubMedCentralCrossRef
Zurück zum Zitat Goodwin JS, Zhang DD, Ostir GV (2004) Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc 52:106–111PubMedPubMedCentralCrossRef Goodwin JS, Zhang DD, Ostir GV (2004) Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc 52:106–111PubMedPubMedCentralCrossRef
Zurück zum Zitat Hjerl K et al (2003) Depression as a prognostic factor for breast cancer mortality. Psychosomatics 44:24–30PubMedCrossRef Hjerl K et al (2003) Depression as a prognostic factor for breast cancer mortality. Psychosomatics 44:24–30PubMedCrossRef
Zurück zum Zitat Hodgson R, Wildgust HJ, Bushe CJ (2010) Cancer and schizophrenia: is there a paradox? J Psychopharmacol Oxf Engl 24:51–60CrossRef Hodgson R, Wildgust HJ, Bushe CJ (2010) Cancer and schizophrenia: is there a paradox? J Psychopharmacol Oxf Engl 24:51–60CrossRef
Zurück zum Zitat Hu J-M et al (2021) Risk of colorectal cancer in patients with attention-deficit hyperactivity disorder: a nationwide population-based cohort study. Front Psychiatry 12:537137PubMedPubMedCentralCrossRef Hu J-M et al (2021) Risk of colorectal cancer in patients with attention-deficit hyperactivity disorder: a nationwide population-based cohort study. Front Psychiatry 12:537137PubMedPubMedCentralCrossRef
Zurück zum Zitat Indrakusuma AABP, Sadeva IGKA, Kusuma IGNAW, Lesmana CBJ, Wihandani DM (2022) The risk of antipsychotic drugs on breast cancer: a systematic review and meta–analysis. Oman Med J 37:e453PubMedPubMedCentralCrossRef Indrakusuma AABP, Sadeva IGKA, Kusuma IGNAW, Lesmana CBJ, Wihandani DM (2022) The risk of antipsychotic drugs on breast cancer: a systematic review and meta–analysis. Oman Med J 37:e453PubMedPubMedCentralCrossRef
Zurück zum Zitat Jacob L, Bleicher L, Kostev K, Kalder M (2016) Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices. J Cancer Res Clin Oncol 142:447–452PubMedCrossRef Jacob L, Bleicher L, Kostev K, Kalder M (2016) Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices. J Cancer Res Clin Oncol 142:447–452PubMedCrossRef
Zurück zum Zitat Jacob L, Kalder M, Kostev K (2017) Incidence of depression and anxiety among women newly diagnosed with breast or genital organ cancer in Germany. Psychooncology 26:1535–1540PubMedCrossRef Jacob L, Kalder M, Kostev K (2017) Incidence of depression and anxiety among women newly diagnosed with breast or genital organ cancer in Germany. Psychooncology 26:1535–1540PubMedCrossRef
Zurück zum Zitat Kessler RC et al (2007) Lifetime prevalence and age–of–onset distributions of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry 6:168–176PubMedPubMedCentral Kessler RC et al (2007) Lifetime prevalence and age–of–onset distributions of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry 6:168–176PubMedPubMedCentral
Zurück zum Zitat Ko A, Kim K, Sik Son J, Park HY, Park SM (2019) Association of pre–existing depression with all–cause, cancer–related, and noncancer–related mortality among 5–year cancer survivors: a population–based cohort study. Sci. Rep. 91(9):1–9 Ko A, Kim K, Sik Son J, Park HY, Park SM (2019) Association of pre–existing depression with all–cause, cancer–related, and noncancer–related mortality among 5–year cancer survivors: a population–based cohort study. Sci. Rep. 91(9):1–9
Zurück zum Zitat Kostev K, Meister U, Kalder M, Jacob L (2017) Suspected cancer diagnoses made by general practitioners in a population with subsequently confirmed cancer diagnoses in Germany: a retrospective study of 31,628 patients. Oncotarget 8:84540–84545PubMedPubMedCentralCrossRef Kostev K, Meister U, Kalder M, Jacob L (2017) Suspected cancer diagnoses made by general practitioners in a population with subsequently confirmed cancer diagnoses in Germany: a retrospective study of 31,628 patients. Oncotarget 8:84540–84545PubMedPubMedCentralCrossRef
Zurück zum Zitat Krebber AMH et al (2014) Prevalence of depression in cancer patients: a meta–analysis of diagnostic interviews and self–report instruments. Psychooncology 23:121–130PubMedCrossRef Krebber AMH et al (2014) Prevalence of depression in cancer patients: a meta–analysis of diagnostic interviews and self–report instruments. Psychooncology 23:121–130PubMedCrossRef
Zurück zum Zitat Kuhnt S et al (2016) Twelve-month and lifetime prevalence of mental disorders in cancer patients. Psychother Psychosom 85:289–296PubMedCrossRef Kuhnt S et al (2016) Twelve-month and lifetime prevalence of mental disorders in cancer patients. Psychother Psychosom 85:289–296PubMedCrossRef
Zurück zum Zitat Kurlansik SL, Maffei MS (2016) Somatic symptom disorder. Am Fam Physician 93:49-54APubMed Kurlansik SL, Maffei MS (2016) Somatic symptom disorder. Am Fam Physician 93:49-54APubMed
Zurück zum Zitat Lee SP et al (2015) The effect of emotional stress and depression on the prevalence of digestive diseases. J Neurogastroenterol Motil 21:273–282PubMedPubMedCentralCrossRef Lee SP et al (2015) The effect of emotional stress and depression on the prevalence of digestive diseases. J Neurogastroenterol Motil 21:273–282PubMedPubMedCentralCrossRef
Zurück zum Zitat Leutgeb R, Berger S, Szecsenyi J, Laux G (2018) Patients with somatoform disorders: more frequent attendance and higher utilization in primary Out–of–Hours care? PLoS ONE 13:e0202546PubMedPubMedCentralCrossRef Leutgeb R, Berger S, Szecsenyi J, Laux G (2018) Patients with somatoform disorders: more frequent attendance and higher utilization in primary Out–of–Hours care? PLoS ONE 13:e0202546PubMedPubMedCentralCrossRef
Zurück zum Zitat Luger TM, Suls J, Vander Weg MW (2014) How robust is the association between smoking and depression in adults? A meta–analysis using linear mixed–effects models. Addict. Behav. 39:1418–1429PubMedCrossRef Luger TM, Suls J, Vander Weg MW (2014) How robust is the association between smoking and depression in adults? A meta–analysis using linear mixed–effects models. Addict. Behav. 39:1418–1429PubMedCrossRef
Zurück zum Zitat Mogavero MP, DelRosso LM, Fanfulla F, Bruni O, Ferri R (2021) Sleep disorders and cancer: state of the art and future perspectives. Sleep Med Rev 56:101409PubMedCrossRef Mogavero MP, DelRosso LM, Fanfulla F, Bruni O, Ferri R (2021) Sleep disorders and cancer: state of the art and future perspectives. Sleep Med Rev 56:101409PubMedCrossRef
Zurück zum Zitat Murray AM, Toussaint A, Althaus A, Löwe B (2016) The challenge of diagnosing non–specific, functional, and somatoform disorders: a systematic review of barriers to diagnosis in primary care. J Psychosom Res 80:1–10PubMedCrossRef Murray AM, Toussaint A, Althaus A, Löwe B (2016) The challenge of diagnosing non–specific, functional, and somatoform disorders: a systematic review of barriers to diagnosis in primary care. J Psychosom Res 80:1–10PubMedCrossRef
Zurück zum Zitat Ni L et al (2019) Mortality of site–specific cancer in patients with schizophrenia: a systematic review and meta–analysis. BMC Psychiatry 19:323PubMedPubMedCentralCrossRef Ni L et al (2019) Mortality of site–specific cancer in patients with schizophrenia: a systematic review and meta–analysis. BMC Psychiatry 19:323PubMedPubMedCentralCrossRef
Zurück zum Zitat Nunn R (2017) “It’s not all in my head!”—the complex relationship between rare diseases and mental health problems. Orphanet J Rare Dis 12:29PubMedPubMedCentralCrossRef Nunn R (2017) “It’s not all in my head!”—the complex relationship between rare diseases and mental health problems. Orphanet J Rare Dis 12:29PubMedPubMedCentralCrossRef
Zurück zum Zitat Patten SB et al (2018) Patterns of association of chronic medical conditions and major depression. Epidemiol Psychiatr Sci 27:42PubMedCrossRef Patten SB et al (2018) Patterns of association of chronic medical conditions and major depression. Epidemiol Psychiatr Sci 27:42PubMedCrossRef
Zurück zum Zitat Pohontsch NJ et al (2018) Coding of medically unexplained symptoms and somatoform disorders by general practitioners—an exploratory focus group study. BMC Fam Pract 19:129PubMedPubMedCentralCrossRef Pohontsch NJ et al (2018) Coding of medically unexplained symptoms and somatoform disorders by general practitioners—an exploratory focus group study. BMC Fam Pract 19:129PubMedPubMedCentralCrossRef
Zurück zum Zitat Rahman T et al (2022) Risk of breast cancer with prolactin elevating antipsychotic drugs: an observational study of US women (Ages 18–64 Years). J Clin Psychopharmacol 42:7PubMedPubMedCentralCrossRef Rahman T et al (2022) Risk of breast cancer with prolactin elevating antipsychotic drugs: an observational study of US women (Ages 18–64 Years). J Clin Psychopharmacol 42:7PubMedPubMedCentralCrossRef
Zurück zum Zitat Raison CL et al (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment–resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiat 70:31–41CrossRef Raison CL et al (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment–resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiat 70:31–41CrossRef
Zurück zum Zitat Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K (2018) Basic characteristics and representativeness of the German disease analyzer database. Int J Clin Pharmacol Ther 56:459–466PubMedCrossRef Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K (2018) Basic characteristics and representativeness of the German disease analyzer database. Int J Clin Pharmacol Ther 56:459–466PubMedCrossRef
Zurück zum Zitat Salm S et al (2021) Mental disorders and utilization of mental health services in newly diagnosed cancer patients: an analysis of German health insurance claims data. Psychooncology 30:312–320PubMedCrossRef Salm S et al (2021) Mental disorders and utilization of mental health services in newly diagnosed cancer patients: an analysis of German health insurance claims data. Psychooncology 30:312–320PubMedCrossRef
Zurück zum Zitat Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients. Cancer 115:5349–5361PubMedCrossRef Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients. Cancer 115:5349–5361PubMedCrossRef
Zurück zum Zitat Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V (2012) Multifaceted link between cancer and inflammation. Biosci Rep 32:1–15PubMedCrossRef Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V (2012) Multifaceted link between cancer and inflammation. Biosci Rep 32:1–15PubMedCrossRef
Zurück zum Zitat Shah E, Rezaie A, Riddle M, Pimentel M (2014) Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence? Ann Gastroenterol q Publ Hell Soc Gastroenterol 27:224–230 Shah E, Rezaie A, Riddle M, Pimentel M (2014) Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence? Ann Gastroenterol q Publ Hell Soc Gastroenterol 27:224–230
Zurück zum Zitat Sotelo JL, Musselman D, Nemeroff C (2014) The biology of depression in cancer and the relationship between depression and cancer progression. Int Rev Psychiatry 26:16–30PubMedCrossRef Sotelo JL, Musselman D, Nemeroff C (2014) The biology of depression in cancer and the relationship between depression and cancer progression. Int Rev Psychiatry 26:16–30PubMedCrossRef
Zurück zum Zitat Steffen A, Nübel J, Jacobi F, Bätzing J, Holstiege J (2020) Mental and somatic comorbidity of depression: a comprehensive cross–sectional analysis of 202 diagnosis groups using German nationwide ambulatory claims data. BMC Psychiatry 20:1–15CrossRef Steffen A, Nübel J, Jacobi F, Bätzing J, Holstiege J (2020) Mental and somatic comorbidity of depression: a comprehensive cross–sectional analysis of 202 diagnosis groups using German nationwide ambulatory claims data. BMC Psychiatry 20:1–15CrossRef
Zurück zum Zitat Su K et al (2022) A broken circadian clock: the emerging neuro–immune link connecting depression to cancer. Brain Behav. Immun. Health. 26:100533PubMedPubMedCentralCrossRef Su K et al (2022) A broken circadian clock: the emerging neuro–immune link connecting depression to cancer. Brain Behav. Immun. Health. 26:100533PubMedPubMedCentralCrossRef
Zurück zum Zitat Varela-Rey M, Woodhoo A, Martinez-Chantar M-L, Mato JM, Lu SC (2013) Alcohol, DNA methylation, and cancer. Alcohol Res Curr Rev 35:25–35 Varela-Rey M, Woodhoo A, Martinez-Chantar M-L, Mato JM, Lu SC (2013) Alcohol, DNA methylation, and cancer. Alcohol Res Curr Rev 35:25–35
Zurück zum Zitat Virgilsen LF et al (2022) Routes to cancer diagnosis for patients with pre–existing psychiatric disorders: a nationwide register–based cohort study. BMC Cancer 22:472PubMedPubMedCentralCrossRef Virgilsen LF et al (2022) Routes to cancer diagnosis for patients with pre–existing psychiatric disorders: a nationwide register–based cohort study. BMC Cancer 22:472PubMedPubMedCentralCrossRef
Zurück zum Zitat Wang PS et al (2002) Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry 59:1147–1154PubMedCrossRef Wang PS et al (2002) Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry 59:1147–1154PubMedCrossRef
Zurück zum Zitat Wittchen HU et al (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:655–679PubMedCrossRef Wittchen HU et al (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:655–679PubMedCrossRef
Zurück zum Zitat Xu D et al (2017) Lower risk of liver cancer in patients with schizophrenia: a systematic review and meta–analysis of cohort studies. Oncotarget 8:102328–102335PubMedPubMedCentralCrossRef Xu D et al (2017) Lower risk of liver cancer in patients with schizophrenia: a systematic review and meta–analysis of cohort studies. Oncotarget 8:102328–102335PubMedPubMedCentralCrossRef
Metadaten
Titel
Psychiatric disorder and its association with gastrointestinal cancer: a retrospective cohort study with 45,842 patients in Germany
verfasst von
Hannah Moessinger
Louis Jacob
Lee Smith
Ai Koyanagi
Karel Kostev
Publikationsdatum
12.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 16/2023
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-023-05229-5

Weitere Artikel der Ausgabe 16/2023

Journal of Cancer Research and Clinical Oncology 16/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.